NR5A2 and esophageal cancer: Further analysis using TargetScan Release 6.2 predicted multiple miRNA target binding sites in the 3′UTR sequence of NR5A2, which meets the R-squared value of Pearson correlation analysis that showed the contribution of miR-139-5p to NR5A2 expression only accounted for approximately 8% in esophageal cancer patients.